Skip to Content

Durvalumab (Imfinzi) and FLOT (Fluorouracil (5-FU), Leucovorin, Oxaliplatin, Docetaxel)

Treatment Given by Infusion

Generic : Durvalumab (dur-VAL-yoo-mab), Fluorouracil (floor-oh-YOOR-uh-sil), Leucovorin (LOO-koh-VOR-in), Oxaliplatin (ok-SA-lih-pla-tin), and Docetaxel (DOH-seh-TAK-sil)
Brand : Imfinzi (im-FIN-zee), Eloxatin (eh-LOK-sah-tin), and Taxotere (TAK-soh-teer)
Download In :
Download 0.81MB
Last Update : October 28, 2025

About this Treatment

The combination is durvalumab and FLOT (fluorouracil (5-FU), leucovorin, oxaliplatin, docetaxel) is used for stomach cancer and cancer where the esophagus joins the stomach.

What are Patient Education Sheets (PES)?

A Patient Education Sheet (PES) is a practical tool created with the unique needs of patients with cancer in mind. Each sheet translates complex treatment information into clear, patient-friendly language. They provide easy-to-follow medication schedules and guidance on managing potential side effects, helping patients and their caregivers feel informed and supported.

These resources are pulled directly by healthcare providers, who can download and print them for distribution during patient visits. This ensures that patients and caregivers leave the clinic with a reliable, easy-to-understand reference tailored to their treatment.

In addition to the standard content, PES documents are also editable in designated sections. Providers can add personalized details such as counseling notes, local resources, or contact information, making each sheet specific to the patient’s care journey.